Jinyong Investment subsidiary spent a total of 142,500 Oriental Selected Shares

Jinyong Investment (01328) announced that on May 13, 2024, Redwood, a wholly-owned subsidiary of the company, purchased a total of 142,500 shareholder-selected shares at a total cost of about HK$2.341 million (not including transaction costs) through in-market transactions carried out on the Stock Exchange, which is equivalent to approximately HK$16.43 per share of Oriental Selected Shares. Redwood purchased a total of 711,500 owner-selected shares during the 12 month period prior to the date of purchase, at a total cost of approximately HK$11.38 million (not including transaction costs). After these purchases, the Group held a total of 8

新浪港股20:41 ET

Xinniu Technology completed the placement of 157 million shares to raise approximately HK$43.6 million

Xinniu Technology (09600) announced that all conditions of the placement agreement have been met, and the placement matters have been completed on May 14, 2024. A total of 157 million shares have been successfully placed by the placement agent to no less than six undertakers at the placement price of HK$0.28 per share in accordance with the terms and conditions of the placement agreement. The net proceeds from the placement (after deducting placement commissions and other related expenses) are approximately HK$43.6 million and will be used to supplement the Group's general working capital.

新浪港股20:39 ET

Cat Poop Coffee Holdings plans to sell a maximum of 221 million shares at a discount of about 19.10% to raise about HK$30.94 million

Cat Poop Coffee Holdings (01869) announced that on May 14, 2024 (after the trading period), the company entered into a placement agreement with the placement agent. According to this, the company has agreed to place up to 221 million shares of placement shares at a placement price of HK$0.144 per share through the placement agent on a best-effort basis. Such undertakers are third parties, institutions or other professional investors independent of the company and its related parties. Placed shares will be allocated and issued in accordance with a general mandate. Assuming that between the date of this announcement and the date of completion of the placement, there will be no issued share capital of the company

新浪港股20:32 ET

On May 14, Yao Ming Biotech spent approximately HK$398.632 million to repurchase 2,725 million shares

Pharmaceutical Biotech (02269) announced that on May 14, 2024, it spent approximately HK$398.632 million to repurchase 2,725 million shares at a repurchase price of HK$14.42-15 per share.

新浪港股20:24 ET

Zhengwei Group plans to discount approximately 4.83% of its shares and raise the maximum net amount of HK$20.72 million

Zhengwei Group (02147) announced that on May 14, 2024, the company plans to place up to 160 million shares, which is equivalent to about 16.67% of the company's expanded issued share capital. The placement price was HK$0.138 per share, a discount of approximately 4.83% from the closing price of HK$0.145 per share on May 14. Assuming that all of the placed shares are fully placed, the maximum amount of proceeds from the placement will be HK$22.08 million. The net proceeds from the placement are expected to be approximately HK$20.72 million. The Company intends to use the net proceeds from the placement as the Group's general working capital.

新浪港股20:00 ET

McFTSE's public offering received 5.95 times the subscription price of HK$43.6 per share

Maifushi (02556) announced the allotment results. The company sold 5.9497 million shares globally, accounting for 10% of the public offering and 90% of the international offering. The final sale price was HK$43.6, with a net raise of approximately HK$181 million from the global sale. Each trading unit is 100 shares. It is expected that the shares will be traded on the Stock Exchange at 9:00 a.m. (Hong Kong time) on May 16, 2024 (Thursday). Among them, the public sale received 5.95 times the subscription, and the international sale received 1.03 times the subscription.

新浪港股19:59 ET